Publications

Title

Author

Year

Progress with the PfSPZ Vaccine for malaria.

GREENWOOD, B;

2017

The Lancet infectious diseases, (2017).17 5 10.1016/S1473-3099(17)30105-6.

Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda.

SSEWANYANA, I; ARINAITWE, E; Nankabirwa, JI; Yeka, A; Sullivan, R; Kamya, MR; Rosenthal, PJ; Dorsey, G; Mayanja-Kizza, H; DRAKELEY, C; Greenhouse, B; TETTEH, KK A;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1721-3.

The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial.

NASH, S; Mentzer, AJ; Lule, SA; Kizito, D; Smits, G; Van der Klis, FR M; ELLIOTT, AM;

2017

PLoS neglected tropical diseases, (2017).11 2 10.1371/journal.pntd.0005213.

Trachoma prevalence and age-specific prevalence of anti-Pgp3 antibodies from Lower River Region and Upper River Region, The Gambia.

Migchelsen, S; MABEY, D;

2017

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2017). 10.17037/DATA.130.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.

SUNDARAM, N; CHEN, C; Yoong, J; Luvsan, M-E; Fox, K; Sarankhuu, A; La Vincente, S; JIT, M;

2017

Vaccine, (2017).35 7 10.1016/j.vaccine.2016.12.070.

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.

RHODES, SJ; Sarfas, C; KNIGHT, GM; White, A; Pathan, AA; McShane, H; Evans, TG; FLETCHER, H; Sharpe, S; WHITE, RG;

2017

Clinical and vaccine immunology, (2017).24 3 10.1128/CVI.00525-16.

IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN THE GAMBIA: POPULATION-BASED SURVEILLANCE OVER 9 YEARS.

Mackenzie, G; Hill, P; JEFFRIES, D; Hossain, I; Ndiaye, M; Badji, H; Ikumapayi, U; Salaudeen, R; Jarju, S; Antonio, M; Ceesay, L; Sowe, D; Jasseh, M; Mulhollan, K; Knoll, M; Levine, O; Howie, S; Adegbola, R; GREENWOOD, B; Corrah, T;

2017

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2017).97 5

SAFETY AND IMMUNOGENICITY OF MONOVALENT AD26. ZEBOV AND MULTIVALENT MVA-BN-FILO HETEROLOGOUS PRIME-BOOST VACCINE REGIMENS AGAINST EBOLA IN AFRICAN HEALTHY ADULT VOLUNTEERS.

ANYWAINE, Z; Praygod, G; Anzala, O; Kalluvya, S; Kaleebu, P; Mutua, G; WHITWORTH, H; Luhn, K; Robinson, C; WATSON-JONES, D; Douoguih, M;

2017

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2017).97 5

Vaccination uptake and health service access amongst Polish and Romanian communitiesin England: a qualitative interview study – research summary.

BELL, S; Zatoński, M; MOUNIER-JACK, S;

2017

Journal of Health Inequalities, (2017).3 2 10.5114/jhi.2017.74213.

Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study.

Toh, ZQ; Russell, FM; Reyburn, R; Fong, J; Tuivaga, E; Ratu, T; Nguyen, CD; Devi, R; Kama, M; Matanitobua, S; Tabrizi, SN; Garland, SM; Sinha, R; Frazer, I; Tikoduadua, L; Kado, J; Rafai, E; MULHOLLAND, EK; Licciardi, PV;

2016

Clinical infectious diseases, (2016).64 7 10.1093/cid/ciw865.